Histamine H3 receptor antagonists – Roles in neurological and endocrine diseases and diabetes mellitus

This publication has 160 references indexed in Scilit:

• The histamine H3 receptor: from discovery to clinical trials with pitolisant
  British Journal of Pharmacology, 2011
• Temporal lobe epilepsy induces intrinsic alterations in Na channel gating in layer II medial entorhinal cortex neurons
  Neurobiology of Disease, 2011
• Histamine H₃ receptor activation decreases kainate-induced hippocampal gamma oscillations in vitro by action potential desynchronization in pyramidal neurons
  2010
• Regional Differential Effects of the Novel Histamine H3 Receptor Antagonist 6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on Histamine Release in the Central Nervous System of Freely Moving Rats
  The Journal of Pharmacology and Experimental Therapeutics, 2010
• Differential effects of acute and repeat dosing with the H₃antagonist GSK189254 on the sleep–wake cycle and narcoleptic episodes in Ox−/− mice
  British Journal of Pharmacology, 2009
• Mediators of Inflammation in Acute Kidney Injury
  Mediators of Inflammation, 2009
• The histamine H₃receptor: an attractive target for the treatment of cognitive disorders
  British Journal of Pharmacology, 2008
• Gamma oscillations dynamically couple hippocampal CA3 and CA1 regions during memory task performance
  Proceedings of the National Academy of Sciences, 2007
• Histaminergic and glycinergic modulation of GABA release in the vestibular nuclei of normal and labyrinthectomised rats
  The Journal of Physiology, 2006
• Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus
  Proceedings of the National Academy of Sciences, 2006